Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Octagon Therapeutics
3113
Octagon Therapeutics
Technology
Biotechnology
Health Care
Medical
Therapeutics
The Pew Trusts estimates that, by 2050, resistant infections will be responsible for more deaths than cancer. Octagon is developing a vitally important new class of antibiotics to address these bacterial threats.
Suggest edits
Founded
2017
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Xconomy
Money Mover
Biogen
HubSpot
Formlabs
Akamai
General Catalyst
Companies in the same industry
Seattle Genetics
Biomoti
Encore Vision Inc.
LabGenius
Grid Therapeutics
Akrevia Therapeutics, Inc.
Candel Therapeutics
Twentyeight-Seven Therapeutics
Moderna Therapeutics
Neuronetics, Inc.
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Latest funding
Undisclosed amount
Seed fund - 2018
MassChallenge
Team Size
2
Employees
I work here
Location
Cambridge
,
United States
Headquarters
Explore Cambridge
FinSMEs
Octagon Therapeutics Closes Financing Round
Health
Funding
Science
